ATE207485T1 - Ein triazolylmethyl-indol-ethylamin-bisulfat-salz - Google Patents
Ein triazolylmethyl-indol-ethylamin-bisulfat-salzInfo
- Publication number
- ATE207485T1 ATE207485T1 AT96925277T AT96925277T ATE207485T1 AT E207485 T1 ATE207485 T1 AT E207485T1 AT 96925277 T AT96925277 T AT 96925277T AT 96925277 T AT96925277 T AT 96925277T AT E207485 T1 ATE207485 T1 AT E207485T1
- Authority
- AT
- Austria
- Prior art keywords
- ethylamin
- triazolylmethyl
- indole
- bisulphate salt
- salt
- Prior art date
Links
- -1 INDOLE-ETHYLAMIN BISULPHATE SALT Chemical compound 0.000 title 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical class S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- ULFRLSNUDGIQQP-UHFFFAOYSA-N rizatriptan Chemical compound C1=C2C(CCN(C)C)=CNC2=CC=C1CN1C=NC=N1 ULFRLSNUDGIQQP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US105595P | 1995-07-11 | 1995-07-11 | |
| GBGB9602977.2A GB9602977D0 (en) | 1996-02-13 | 1996-02-13 | A triazolylmethyl-indole ethylamine bisulfate salt |
| PCT/US1996/011370 WO1997003068A1 (en) | 1995-07-11 | 1996-07-08 | A triazolylmethyl-indole ethylamine bisulfate salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE207485T1 true ATE207485T1 (de) | 2001-11-15 |
Family
ID=26308694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96925277T ATE207485T1 (de) | 1995-07-11 | 1996-07-08 | Ein triazolylmethyl-indol-ethylamin-bisulfat-salz |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0840733B1 (de) |
| JP (1) | JPH11508916A (de) |
| AT (1) | ATE207485T1 (de) |
| AU (1) | AU6542896A (de) |
| CA (1) | CA2225416C (de) |
| DE (1) | DE69616335T2 (de) |
| ES (1) | ES2163032T3 (de) |
| WO (1) | WO1997003068A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6231833B1 (en) | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| MXPA04003928A (es) * | 2001-10-26 | 2005-03-31 | Dey L P | Solucion para inhalacion de albuterol, sistema, equipo y metodo para aliviar sintomas de asma pediatrica. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
| DE69318212T2 (de) * | 1992-06-05 | 1998-11-19 | Merck Sharp & Dohme | Sulfatsalz von einem substituierten Triazol, seine pharmazeutischen Zusammensetzungen und ihre Verwendung in Therapie |
| US5567824A (en) * | 1994-05-24 | 1996-10-22 | Merck & Co., Inc. | Palladium catalyzed ring closure of triazolyltryptamine |
-
1996
- 1996-07-08 AT AT96925277T patent/ATE207485T1/de not_active IP Right Cessation
- 1996-07-08 JP JP9505920A patent/JPH11508916A/ja active Pending
- 1996-07-08 AU AU65428/96A patent/AU6542896A/en not_active Abandoned
- 1996-07-08 EP EP96925277A patent/EP0840733B1/de not_active Expired - Lifetime
- 1996-07-08 DE DE69616335T patent/DE69616335T2/de not_active Expired - Lifetime
- 1996-07-08 WO PCT/US1996/011370 patent/WO1997003068A1/en not_active Ceased
- 1996-07-08 ES ES96925277T patent/ES2163032T3/es not_active Expired - Lifetime
- 1996-07-08 CA CA002225416A patent/CA2225416C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11508916A (ja) | 1999-08-03 |
| DE69616335D1 (de) | 2001-11-29 |
| WO1997003068A1 (en) | 1997-01-30 |
| CA2225416C (en) | 2009-02-24 |
| EP0840733B1 (de) | 2001-10-24 |
| DE69616335T2 (de) | 2002-07-11 |
| AU6542896A (en) | 1997-02-10 |
| EP0840733A1 (de) | 1998-05-13 |
| ES2163032T3 (es) | 2002-01-16 |
| CA2225416A1 (en) | 1997-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9609250A (pt) | 2,4,5-fenilcetoenóis trisubstituídos | |
| DE69615933D1 (de) | Durchflussdruckregelgerät | |
| ATE254628T1 (de) | Meiose regulierende verbindungen. | |
| TR199600481A2 (tr) | Tedavi edici amidler. | |
| TR199600849A2 (tr) | 1alfa-26 dihidroksi -D-homo-vitamin D3. | |
| ITBO950154A0 (it) | Apparecchio per la vaporizzazione di soluzioni insetticide o simili | |
| ITMI961166A0 (it) | Dispositivo regolatore di pressione | |
| BR9607789A (pt) | Regulador de pressão de fluxo | |
| FI960793A0 (fi) | Adaptiivinen tasavirran tehonsyötön esisäädin | |
| FI974640L (fi) | Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit | |
| DE59607589D1 (de) | N-aryl-1,2,4-triazolin-5-one | |
| NO307420B1 (no) | Sulfatsaltet av en substituert triazol, farmasøytiske preparater derav, og deres anvendelse innen terapi | |
| DE69616608D1 (de) | Stromversorgung für vibrierende Kompressoren | |
| ATE207485T1 (de) | Ein triazolylmethyl-indol-ethylamin-bisulfat-salz | |
| ITMI950050A0 (it) | Erogatore per autorestiratori subacquei. | |
| FI952993A7 (fi) | Ilmentämisjärjestelmä, intergraatiovektori ja tällä integraatioverkolla transformoitu solu | |
| FR2748919B1 (fr) | Fauteuil reglable, notamment pour donner le biberon | |
| ES2148753T3 (es) | Sal de metilpirrolidinilindol. | |
| MY108739A (en) | Imidazole, triazole and tetrazole derivatives | |
| FR2730489B1 (fr) | Derives de 1-(2-(vinyl-substitues))-5h-2,3-benzodiazepine | |
| KR970009845U (ko) | 논 물공급 조절기 | |
| KR970040985U (ko) | 압력 레귤레이터 | |
| SE9500374D0 (sv) | Tryckregulator | |
| KR970041853U (ko) | 압력 조정장치 | |
| ITRM950686A1 (it) | Hcg nel sarcoma di kaposi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |